Huadong Medicine Stock Overview
- Ticker: Huadong Medicine (000963.SZ)
- Last 24‑hour performance: flat (0 %) as of 12:35 PM Central Europe on Friday, 23 March.
- Current price: CN¥ 26.37 on major exchanges.
- Shares outstanding: 1.8 billion.
- Market capitalization: CN¥ 6.4 billion.
- Volume traded in last 24 h: CN¥ 310.1 million.
- Month‑end change: down 1.89 %.
- 200‑day simple moving average: CN¥ 28.23.
- 52‑week high: CN¥ 43.78 (13 November 2025).
- 52‑week low: CN¥ 25.63 (29 June 2026).
Recent Market Commentary
Goldman Sachs has increased its outlook for the global weight‑loss medication market. The firm cites rising obesity rates and growing awareness of GLP‑1 therapies, particularly in large emerging markets. The revised forecast estimates the market size to exceed CN¥ 1 trillion by 2030, a rise of approximately 13 % from the previous estimate.
In China, the sector is projected to expand as new treatments receive approval and domestic manufacturers enter the market. The industry is shifting from niche, high‑price injectable products toward more affordable, long‑term weight‑management options. Companies that supply peptide raw materials, manufacture these products, or develop novel oral and long‑acting formulations are positioned to benefit.
Investment discussions are increasingly focused on the profitability and sustainability of individual players, rather than merely the overall market size, with emphasis on firms that can preserve high margins amid regulatory changes and competition.
Performance of Related Stocks (Last 24 h)
| Company | Ticker | 24‑h change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Wuxi Zhenhua Auto Parts | 605319.SS | 0 % | CNY 20.1 | CNY 7.1 bn | 20.07 |
| Jiangsu Yanghe Distillery | 002304.SZ | 0 % | CNH 37.2 | CNH 7.7 bn | 119.86 |
| Beijing Zhidemai Technology | 300785.SZ | 0 % | CNY 34.05 | CNY 7.1 bn | 78.65 |
| Landun Photoelectron | 300862.SZ | 0 % | CNY 36.08 | CNY 7.1 bn | – |
| China Boya Bio‑P | 300294.SZ | 0 % | CNY 14.01 | CNY 7.1 bn | – |
Company Background
Huadong Medicine Co., Ltd is headquartered in Hangzhou, China. The company operates in the healthcare sector, producing and selling a range of pharmaceutical products, including antibiotics, proprietary Chinese medicines, chemically synthesized medicines, and genetic engineering drugs. Its operations also extend to real estate development.
